Indstilling for skærmlæser

Search

Vælg sprog

Gå til sekundær menu

Gå direkte til indholdet

Jehovas Vidner

Dansk

Hjerte- og karkirurgi

Optimere hæmostase

Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST).

Ranucci M, Baryshnikova E

Kilde‎: Br J Anaesth 2016;116(5):618-23.

Indekseret‎: PubMed 26893405

DOI‎: 10.1093/bja/aev539

http://www.ncbi.nlm.nih.gov/pubmed/26893405

Recombinant activated factor VII significantly reduces transfusion requirements in cardiothoracic surgery.

Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM

Kilde‎: Drugs R D 2015;15(2):187-94.

Indekseret‎: PubMed 25862216

DOI‎: 10.1007/s40268-015-0093-9

http://www.ncbi.nlm.nih.gov/pubmed/25862216

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Kilde‎: J Am Heart Assoc 2015;4(6):e002066.

Indekseret‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

http://www.ncbi.nlm.nih.gov/pubmed/26037084

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.

Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J.

Kilde‎: Anesthesiology 2011;115(6):1179-1191.

Indekseret‎: PubMed 21970887

DOI‎: 10.1097/ALN.0b013e31823497dd

http://www.ncbi.nlm.nih.gov/pubmed/21970887

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Kilde‎: Anesthesiology 2013;118(1):40-50.

Indekseret‎: PubMed 23249928

DOI‎: 10.1097/ALN.0b013e3182715d4d

http://www.ncbi.nlm.nih.gov/pubmed/23249928

Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.

Menkis AH, Martin J, Cheng DC, Fitzgerald DC, Freedman JJ, Gao C, Koster A, Mackenzie GS, Murphy GJ, Spiess B, Ad N.

Kilde‎: Innovations (Phila) 2012;7(4):229-41.

Indekseret‎: PubMed 23123988

DOI‎: 10.1097/IMI.0b013e3182747699

http://www.ncbi.nlm.nih.gov/pubmed/23123988

Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation.

Dell'Amore A, Caroli G, Nizar A, Cassanelli N, Luciano G, Greco D, Dolci G, Bini A, Stella F.

Kilde‎: Heart Lung Circ 2012;21(11):706-10.

Indekseret‎: PubMed 22842057

DOI‎: 10.1016/j.hlc.2012.06.016

http://www.ncbi.nlm.nih.gov/pubmed/22842057

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products.

Solomon C, Schöchl H, Hanke A, Calatzis A, Hagl C, Tanaka K, Rahe-Meyer N.

Kilde‎: Scand J Clin Lab Invest 2012;72(2):121-8.

Indekseret‎: PubMed 22233480

DOI‎: 10.3109/00365513.2011.643818

http://www.ncbi.nlm.nih.gov/pubmed/22233480

Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate.

Robblee JA, Wilkes PR, Dickie SJ, Rubens FD, Bormanis J.

Kilde‎: Can J Anaesth 2012;59(3):299-303.

Indekseret‎: PubMed 22161243

DOI‎: 10.1007/s12630-011-9647-7

http://www.ncbi.nlm.nih.gov/pubmed/22161243

Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, Liu M, Chen L, Li L.

Kilde‎: Anesth Analg 2012;115(2):239-43.

Indekseret‎: PubMed 21737704

DOI‎: 10.1213/ANE.0b013e3182264a11

http://www.ncbi.nlm.nih.gov/pubmed/21737704

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

Kilde‎: J Vasc Surg 2011;53(4):1032-7.

Indekseret‎: PubMed 21215579

DOI‎: 10.1016/j.jvs.2010.07.075

http://www.ncbi.nlm.nih.gov/pubmed/21215579

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.

Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.

Kilde‎: Circulation 2009;120(1):21-7.

Indekseret‎: PubMed 19546387

DOI‎: 10.1161/CIRCULATIONAHA.108.834275

http://www.ncbi.nlm.nih.gov/pubmed/19546387

Influence of body core temperature on blood loss and transfusion requirements during off-pump coronary artery bypass grafting: A comparison of 3 warming systems.

Hofer CK, Worn M, Tavakoli R, Sander L, Maloigne M, Klaghofer R, Zollinger A.

Kilde‎: J Thorac Cardiovasc Surg 2005;129(4):838-43.

Indekseret‎: PubMed 15821652

http://www.ncbi.nlm.nih.gov/pubmed/15821652

A surgeon's guide to herbal supplements.

Tessier DJ, Bash DS.

Kilde‎: J Surg Res 2003;114(1):30-6.

Indekseret‎: PubMed 13678695

http://www.ncbi.nlm.nih.gov/pubmed/13678695


Sektionen om lægebehandling på jw.org er udarbejdet som en informationsressource primært for læger og andre sundhedspersoner. Den giver hverken medicinsk vejledning eller anbefaling af behandling, og den erstatter ikke en velkvalificeret læge. Den lægevidenskabelige litteratur der er henvist til, er ikke udgivet af Jehovas Vidner, men den skitserer alternative strategier til transfusion som kan overvejes. Det er den enkelte læges ansvar at holde sig ajour med den nyeste information, drøfte behandlingsmetoder og hjælpe patienter til at træffe valg der harmonerer med deres lidelse, ønsker, værdier og religiøse overbevisning. Ikke alle anførte strategier er passende eller acceptable for alle patienter.

Til patienter: Søg altid råd hos din egen læge eller den behandlingsansvarlige læge vedrørende medicinske lidelser og behandling. Henvend dig til en læge hvis du har mistanke om at du er syg.

Denne hjemmeside reguleres efter dens anvendelsesvilkår.